ChemoMetec Stock Today

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>CH</div>
ChemoMetec is trading at 233.50 as of the 4th of April 2020, which is 1.08% increase since the beginning of the trading day. The stock's open price was 231.0. ChemoMetec has 45 percent ods of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 30 trading days. Equity ratings for ChemoMetec AS are calculated based on the Macroaxis scoring framework. The performance scores are derived for the period starting the 5th of January 2020 and ending today, the 4th of April 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

  Performance4 100 

ChemoMetec Profile

ChemoMetec AS designs, develops, and produces instruments for a range of applications in cell counting and evaluation in Denmark and internationally. ChemoMetec AS was founded in 1997 and is headquartered in Allerod, Denmark. ChemoMetec operates under Medical Equipment classification in Denmark and is traded on Copenhagen Stock Exchange. more on ChemoMetec
Legal NameChemoMetec AS
Chief Executive OfficerSteen SoendergaardLarsenView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
ChemoMetec AS (CHEMM) is traded on Copenhagen Stock Exchange in Denmark and employs 5 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.36 B. ChemoMetec AS operates under Technology sector and is part of Scientific & Technical Instruments industry. The entity has 15.25 M outstanding shares. CHEMOMETEC has accumulated about 291.32 M in cash with 60.74 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.49.
Check ChemoMetec Probability Of Bankruptcy

ChemoMetec Stock Price Odds Analysis

Odds Down 233.5HorizonTargetOdds Up 233.5
58.80%30 days
Based on normal probability distribution, the odds of ChemoMetec to move above current price in 30 days from now is about 41.07 (This ChemoMetec AS probability density function shows the probability of ChemoMetec Stock to fall within a particular range of prices over 30 days) .

ChemoMetec Stock Top Holders

ChemoMetec AS Risk Profiles

ChemoMetec Stock Against Markets

Did you try this?

Run Fundamentals Matrix Now


Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
All  Next Launch Module
Continue to Trending Equities. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page